| Index | — | P/E | 8.57 | EPS (ttm) | 1.55 | Insider Own | 23.73% | Shs Outstand | 103.67M | Perf Week | 0.00% |
| Market Cap | 1.38B | Forward P/E | 4.36 | EPS next Y | 3.05 | Insider Trans | -0.77% | Shs Float | 101.82M | Perf Month | 5.73% |
| Enterprise Value | 3.17B | PEG | 0.42 | EPS next Q | — | Short Float | 7.84% | Perf Quarter | 3.75% | ||
| Income | 164.00M | P/S | 0.26 | EPS this Y | 12.81% | Short Ratio | 5.19 | Perf Half Y | -16.06% | ||
| Sales | 5.20B | P/B | — | EPS next Y | 24.97% | ROA | 5.75% | Short Interest | 7.99M | Perf YTD | 3.03% |
| Book/sh | -4.50 | P/C | 3.71 | EPS next 5Y | 20.58% | ROE | — | 52W High | 20.40 -34.90% | Perf Year | 71.35% |
| Cash/sh | 3.58 | P/FCF | 3.23 | EPS past 3/5Y | -12.02% -4.50% | ROIC | 18.34% | 52W Low | 7.56 75.66% | Perf 3Y | -10.03% |
| Dividend Est. | — | EV/EBITDA | 6.00 | Sales past 3/5Y | -1.07% -1.89% | Gross Margin | 75.87% | Volatility | 3.96% 3.61% | Perf 5Y | -72.02% |
| Dividend TTM | — | EV/Sales | 0.61 | EPS Y/Y TTM | -51.10% | Oper. Margin | 8.89% | ATR (14) | 0.50 | Perf 10Y | -57.57% |
| Dividend Ex-Date | Feb 28, 2014 | Quick Ratio | 0.68 | Sales Y/Y TTM | 5.54% | Profit Margin | 3.16% | RSI (14) | 51.31 | Recom | 2.50 |
| Dividend Gr. 3/5Y | -21.70% -5.59% | Current Ratio | 1.20 | EPS Q/Q | 28.00% | SMA20 | -1.70% | Beta | 0.72 | Target Price | 19.00 |
| Payout | 0.00% | Debt/Eq | — | Sales Q/Q | 5.40% | SMA50 | 4.36% | Rel Volume | 1.14 | Prev Close | 13.05 |
| Employees | 8,500 | LT Debt/Eq | — | Earnings | Feb 17 | SMA200 | -5.08% | Avg Volume | 1.61M | Price | 13.28 |
| IPO Date | Dec 16, 2004 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 3.56% — | Net Debt/EBITDA | 3.40 | Volume | 1,839,831 | Change | 1.76% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Sep-17-26 | Reiterated | UBS | $21 | |
| May-04-26 | Reiterated | Mizuho Securities | Neutral | $15 → $17 |
| Jan-08-26 | Reiterated | Mizuho | Neutral | $11 → $13 |
| Jan-06-26 | Initiated | Maxim | Buy | $20 |
| Nov-26-25 | Upgrade | Argus Research | Hold → Buy | $15 |
| Mar-21-25 | Upgrade | DA Davidson | Neutral → Buy | $9.50 → $14 |
| Jun-07-24 | Reiterated | Mizuho | Neutral | $10 → $11 |
| Mar-25-24 | Reiterated | DA Davidson | Neutral | $9.50 |
| Mar-21-24 | Reiterated | Mizuho | Neutral | $10 |
| Jul-12-22 | Upgrade | Jefferies | Hold → Buy |
Herbalife Nutrition Ltd. is a global enterprise dedicated to providing comprehensive nutritional solutions. Its market presence extends across various international regions, including North America, Mexico, Central and South America, Europe, the Middle East, Africa, China, and the broader Asia Pacific area. The company’s extensive product catalog caters to several core wellness categories, encompassing weight management, specialized nutritional supplementation, energy and athletic performance, and external personal care. Specifically, its weight management offerings feature items like meal replacements, protein shakes, powdered drink mixes, weight loss aids, and healthy snacks. For targeted nutrition, Herbalife provides functional beverages alongside dietary and nutritional supplements rich in herbs, vitamins, minerals, and other naturally derived ingredients. The outer nutrition range includes products for facial, body, and hair care, while its energy, sports, and fitness segment includes popular items such as N-R-G tea and various energy drinks. In addition to its product lines, Herbalife furnishes supporting materials, which comprise start-up kits, sales tools, informational literature, and educational resources. The company employs a multi-channel distribution strategy, primarily leveraging independent service providers and sales representatives, alongside its own company-operated retail platforms. Founded in Los Angeles, California, in 1980, the organization was known as Herbalife Ltd. until April 2018, when it officially rebranded to Herbalife Nutrition Ltd.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 5,201 | 5,038 | 4,993 | 5,062 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 1,255 | 1,229 | 1,104 | 1,191 | — | — | — | — | — | |
| Gross Profit | 3,946 | 3,809 | 3,889 | 3,871 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 3,514 | 3,447 | 3,508 | 3,525 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | -31 | -80 | -5 | -10 | — | — | — | — | — | |
| Operating Income | 462 | 442 | 386 | 356 | — | — | — | — | — | |
| Interest Expense | 194 | 214 | 218 | 166 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -55 | 48 | 2 | 13 | — | — | — | — | — | |
| Net Income Before Taxes | 214 | 275 | 169 | 203 | — | — | — | — | — | |
| Income Taxes | 50 | 47 | -85 | 61 | — | — | — | — | — | |
| Consolidated Net Income | 164 | 228 | 254 | 142 | — | — | — | — | — | |
| Net Income From Continuing Operations | 164 | 228 | 254 | 142 | — | — | — | — | — | |
| Net Income | 164 | 228 | 254 | 142 | — | — | — | — | — | |
| EPS (Recurring) | 1.60 | 2.22 | 2.53 | 1.44 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 1.60 | 2.22 | 2.53 | 1.44 | — | — | — | — | — | |
| EPS (Diluted) | 1.55 | 2.20 | 2.50 | 1.42 | — | — | — | — | — | |
| EBITDA | 529 | 611 | 509 | 482 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 8.57 | 5.86 | 2.68 | 10.75 | — | — | — | — | — | |
| Price To Sales Ratio | 0.27 | 0.26 | 0.14 | 0.30 | — | — | — | — | — | |
| Gross Margin | 75.87 | 75.61 | 77.89 | 76.47 | — | — | — | — | — | |
| Operating Margin | 8.88 | 8.77 | 7.73 | 7.03 | — | — | — | — | — | |
| Net Margin | 3.15 | 4.53 | 5.09 | 2.81 | — | — | — | — | — | |
| Shares Outstanding | 105 | 103 | 101 | 99 | — | — | — | — | — | |
| Market Capitalization | 1,394 | 1,328 | 676 | 1,511 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| L'Helias Sophie | Director | Jun 04 '26 | Buy | 11.31 | 1,200 | 13,572 | 79,882 | Jun 04 |
| Hicks Troy | Chief Operating Officer | May 19 '26 | Sale | 12.32 | 10,000 | 123,245 | 9,706 | May 20 |
| Hicks Troy | Chief Operating Officer | May 18 '26 | Option Exercise | 9.31 | 83,270 | 775,526 | 77,770 | May 20 |
| Hicks Troy | Chief Operating Officer | May 18 '26 | Sale | 12.93 | 38,377 | 496,311 | 9,062 | May 20 |
| Lamberti Frank | Chief Commercial Officer | May 12 '26 | Sale | 13.50 | 134,982 | 1,822,257 | 36,624 | May 12 |
| Lamberti Frank | Chief Commercial Officer | May 11 '26 | Sale | 13.86 | 7,937 | 110,002 | 171,606 | May 12 |
| L'Helias Sophie | Director | Dec 01 '25 | Buy | 12.70 | 800 | 10,160 | 66,803 | Dec 01 |
| L'Helias Sophie | Director | Nov 26 '25 | Buy | 13.22 | 400 | 5,288 | 66,003 | Dec 01 |
| Cloud Lynda | Director | Nov 18 '25 | Buy | 8.97 | 17,000 | 152,490 | 38,857 | Nov 20 |
| Mendoza Juan Miguel | Director | Jun 05 '25 | Buy | 7.50 | 3,143 | 23,573 | 170,000 | Jun 09 |
| Mendoza Juan Miguel | Director | May 22 '25 | Buy | 6.75 | 5,000 | 33,750 | 166,857 | May 23 |
| Mendoza Juan Miguel | Director | May 02 '25 | Buy | 6.73 | 5,000 | 33,650 | 140,000 | May 06 |
| Mendoza Juan Miguel | Director | Mar 04 '25 | Buy | 8.00 | 2,500 | 20,000 | 135,000 | Mar 06 |
| Mendoza Juan Miguel | Director | Feb 27 '25 | Buy | 8.25 | 5,000 | 41,250 | 132,500 | Mar 03 |
| Mendoza Juan Miguel | Director | Nov 08 '24 | Buy | 8.49 | 2,500 | 21,225 | 127,500 | Nov 13 |